$273 Million is the total value of Altium Capital Management LP's 134 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 60.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BLU | Buy | BELLUS HEALTH INC NEW | $11,954,000 | +41.9% | 1,132,000 | +24.1% | 4.38% | +30.0% |
| KDNY | Sell | CHINOOK THERAPEUTICS INC | $10,322,000 | -4.0% | 525,000 | -14.6% | 3.78% | -12.1% |
| CCXI | CHEMOCENTRYX INC | $8,266,000 | +108.5% | 160,000 | 0.0% | 3.03% | +91.0% | |
| PEPPERLIME HEALTH ACQUSTN CO | $7,343,000 | +1.3% | 735,000 | 0.0% | 2.69% | -7.2% | ||
| ADMA | Sell | ADMA BIOLOGICS INC | $7,007,000 | -11.5% | 2,883,710 | -27.9% | 2.57% | -18.9% |
| CBAY | CYMABAY THERAPEUTICS INC | $6,125,000 | +18.6% | 1,750,000 | 0.0% | 2.25% | +8.7% | |
| INSM | INSMED INC | $5,773,000 | +9.2% | 268,000 | 0.0% | 2.12% | +0.1% | |
| New | GUARDANT HEALTH INCcall | $5,383,000 | – | 100,000 | +100.0% | 1.97% | – | |
| MBTC | NOCTURNE ACQUISITION CORPordinary shares | $5,165,000 | +1.4% | 500,000 | 0.0% | 1.89% | -7.1% | |
| GKOS | Sell | GLAUKOS CORP | $5,164,000 | -0.3% | 97,000 | -14.9% | 1.89% | -8.6% |
| AKRO | New | AKERO THERAPEUTICS INC | $4,767,000 | – | 140,000 | +100.0% | 1.75% | – |
| ITCI | Buy | INTRA-CELLULAR THERAPIES INC | $4,653,000 | +8.7% | 100,000 | +33.3% | 1.71% | -0.4% |
| XTNT | XTANT MED HLDGS INC | $4,496,000 | +38.6% | 6,246,291 | 0.0% | 1.65% | +27.0% | |
| PLRX | New | PLIANT THERAPEUTICS INC | $4,491,000 | – | 215,000 | +100.0% | 1.65% | – |
| ESPR | Sell | ESPERION THERAPEUTICS INC NE | $4,421,000 | -40.2% | 659,869 | -43.3% | 1.62% | -45.2% |
| BCAB | New | BIOATLA INC | $4,258,000 | – | 553,000 | +100.0% | 1.56% | – |
| ILMN | Buy | ILLUMINA INC | $4,197,000 | +127.6% | 22,000 | +120.0% | 1.54% | +108.5% |
| RYTM | New | RHYTHM PHARMACEUTICALS INC | $4,165,000 | – | 170,000 | +100.0% | 1.53% | – |
| VRNA | New | VERONA PHARMA PLCsponsored ads | $4,129,000 | – | 404,000 | +100.0% | 1.51% | – |
| KPTI | Buy | KARYOPHARM THERAPEUTICS INC | $4,095,000 | +29.7% | 750,000 | +7.1% | 1.50% | +18.8% |
| New | ASTRIA THERAPEUTICS INC | $4,023,000 | – | 445,000 | +100.0% | 1.48% | – | |
| EUCR | EUCRATES BIOMEDICAL ACQU COR | $4,008,000 | +1.2% | 400,000 | 0.0% | 1.47% | -7.3% | |
| ANGO | Buy | ANGIODYNAMICS INC | $3,990,000 | +420.2% | 195,000 | +391.9% | 1.46% | +376.5% |
| BLRX | New | BIOLINERX LTDsponsored ads | $3,838,000 | – | 4,149,262 | +100.0% | 1.41% | – |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $3,824,000 | +132.5% | 17,000 | +30.8% | 1.40% | +113.1% |
| RMD | New | RESMED INC | $3,711,000 | – | 17,000 | +100.0% | 1.36% | – |
| NSTG | New | NANOSTRING TECHNOLOGIES INC | $3,576,000 | – | 280,000 | +100.0% | 1.31% | – |
| QUIDELORTHO CORP | $3,574,000 | -26.4% | 50,000 | 0.0% | 1.31% | -32.6% | ||
| GH | Sell | GUARDANT HEALTH INC | $3,553,000 | -16.1% | 66,000 | -37.1% | 1.30% | -23.1% |
| MYGN | Sell | MYRIAD GENETICS INC | $3,549,000 | -11.6% | 186,000 | -15.8% | 1.30% | -19.0% |
| INGN | Sell | INOGEN INC | $3,545,000 | -6.0% | 146,000 | -6.4% | 1.30% | -13.9% |
| AKYA | AKOYA BIOSCIENCES INC | $3,478,000 | -8.6% | 296,000 | 0.0% | 1.28% | -16.2% | |
| Sell | PROCEPT BIOROBOTICS CORP | $3,358,000 | +4.8% | 81,000 | -17.3% | 1.23% | -4.0% | |
| EIGR | EIGER BIOPHARMACEUTICALS INC | $3,313,000 | +19.5% | 440,000 | 0.0% | 1.22% | +9.6% | |
| KROS | KEROS THERAPEUTICS INC | $3,311,000 | +36.2% | 88,000 | 0.0% | 1.21% | +24.8% | |
| NTRA | New | NATERA INC | $3,287,000 | – | 75,000 | +100.0% | 1.20% | – |
| ATEC | New | ALPHATEC HLDGS INC | $2,989,000 | – | 342,000 | +100.0% | 1.10% | – |
| NVRO | Sell | NEVRO CORP | $2,982,000 | -23.6% | 64,000 | -28.1% | 1.09% | -30.0% |
| LNTH | Sell | LANTHEUS HLDGS INC | $2,954,000 | -49.2% | 42,000 | -52.3% | 1.08% | -53.4% |
| SIBN | New | SI-BONE INC | $2,916,000 | – | 167,000 | +100.0% | 1.07% | – |
| VSTM | VERASTEM INC | $2,550,000 | -26.7% | 3,000,000 | 0.0% | 0.94% | -32.9% | |
| TMPM | TURMERIC ACQUISITION CORPcl a | $2,540,000 | +0.9% | 254,000 | 0.0% | 0.93% | -7.6% | |
| CTIC | New | CTI BIOPHARMA CORP | $2,485,000 | – | 427,000 | +100.0% | 0.91% | – |
| RNA | AVIDITY BIOSCIENCES INC | $2,450,000 | +12.4% | 150,000 | 0.0% | 0.90% | +3.0% | |
| TWST | New | TWIST BIOSCIENCE CORP | $2,396,000 | – | 68,000 | +100.0% | 0.88% | – |
| SRSA | SARISSA CAPITAL ACQUISITN COcl a | $2,250,000 | +1.1% | 225,000 | 0.0% | 0.82% | -7.3% | |
| ISEE | Sell | IVERIC BIO INC | $2,243,000 | -1.2% | 125,000 | -47.0% | 0.82% | -9.5% |
| KRMD | KORU MEDICAL SYSTEMS INC | $2,220,000 | -11.9% | 995,500 | 0.0% | 0.81% | -19.2% | |
| New | ARCELLX INC | $2,159,000 | – | 115,000 | +100.0% | 0.79% | – | |
| OCUL | Sell | OCULAR THERAPEUTIX INC | $2,146,000 | -23.2% | 517,133 | -25.6% | 0.79% | -29.6% |
| ACET | ADICET BIO INC | $2,133,000 | -2.6% | 150,000 | 0.0% | 0.78% | -10.7% | |
| INSP | Sell | INSPIRE MED SYS INC | $2,128,000 | -51.5% | 12,000 | -50.0% | 0.78% | -55.5% |
| Buy | 2SEVENTY BIO INC | $2,037,000 | +85.9% | 140,000 | +68.7% | 0.75% | +70.2% | |
| TG VENTURE ACQUISITION CORPunit 08/15/2028 | $2,020,000 | +1.0% | 200,000 | 0.0% | 0.74% | -7.4% | ||
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $2,018,000 | -5.9% | 19,000 | -13.6% | 0.74% | -13.8% |
| New | LAKESHORE ACQUISITION II CORordinary shares | $2,016,000 | – | 200,000 | +100.0% | 0.74% | – | |
| JYAC | JIYA ACQUISITION CORP | $1,994,000 | +0.9% | 200,000 | 0.0% | 0.73% | -7.6% | |
| QURE | New | UNIQURE NV | $1,970,000 | – | 105,000 | +100.0% | 0.72% | – |
| COLL | COLLEGIUM PHARMACEUTICAL INC | $1,858,000 | -9.6% | 116,000 | 0.0% | 0.68% | -17.3% | |
| VCEL | New | VERICEL CORP | $1,856,000 | – | 80,000 | +100.0% | 0.68% | – |
| AFMD | New | AFFIMED N V | $1,854,000 | – | 900,000 | +100.0% | 0.68% | – |
| CARA | Sell | CARA THERAPEUTICS INC | $1,806,000 | -44.0% | 193,000 | -45.4% | 0.66% | -48.7% |
| EYPT | EYEPOINT PHARMACEUTICALS INC | $1,776,000 | +0.5% | 224,541 | 0.0% | 0.65% | -7.9% | |
| MDWD | New | MEDIWOUND LTD | $1,775,000 | – | 1,276,948 | +100.0% | 0.65% | – |
| UBX | New | UNITY BIOTECHNOLOGY INC | $1,687,000 | – | 4,270,000 | +100.0% | 0.62% | – |
| HILLMAN SOLUTIONS CORP | $1,666,000 | -12.7% | 221,000 | 0.0% | 0.61% | -20.0% | ||
| TRVI | Sell | TREVI THERAPEUTICS INC | $1,642,000 | -54.5% | 1,066,157 | -17.0% | 0.60% | -58.3% |
| GOSS | Sell | GOSSAMER BIO INC | $1,617,000 | -25.7% | 135,000 | -48.1% | 0.59% | -31.9% |
| CSTL | New | CASTLE BIOSCIENCES INC | $1,565,000 | – | 60,000 | +100.0% | 0.57% | – |
| ALKS | Buy | ALKERMES PLC | $1,563,000 | +191.6% | 70,000 | +288.9% | 0.57% | +167.8% |
| DIGITAL HEALTH ACQUISITION Cunit 11/02/2026 | $1,545,000 | +2.0% | 150,000 | 0.0% | 0.57% | -6.6% | ||
| AULT DISRUPTIVE TECHS CORP | $1,512,000 | +0.6% | 150,000 | 0.0% | 0.55% | -7.8% | ||
| FATBW | FAT BRANDS INC*w exp 07/16/202 | $1,171,000 | +21.3% | 227,000 | 0.0% | 0.43% | +11.1% | |
| QTRX | New | QUANTERIX CORP | $1,047,000 | – | 95,000 | +100.0% | 0.38% | – |
| LRMR | New | LARIMAR THERAPEUTICS INC | $1,024,000 | – | 320,000 | +100.0% | 0.38% | – |
| INDUSTRIAL HUMAN CAPITAL INC | $1,015,000 | +1.2% | 100,000 | 0.0% | 0.37% | -7.2% | ||
| RELATIVITY ACQUISITION CORPunit 02/10/2027 | $1,008,000 | -1.7% | 100,000 | 0.0% | 0.37% | -9.8% | ||
| WESTERN ACQSTN VENTURES CORPunit 09/01/2026 | $1,010,000 | +1.0% | 100,000 | 0.0% | 0.37% | -7.5% | ||
| MURPHY CANYON ACQUISITION COunit 01/25/2027 | $1,004,000 | -0.8% | 100,000 | 0.0% | 0.37% | -9.1% | ||
| BLSA | BCLS ACQUISITION CORP | $1,002,000 | +1.2% | 100,000 | 0.0% | 0.37% | -7.3% | |
| OPY ACQUISITION CORP I | $993,000 | +0.9% | 100,000 | 0.0% | 0.36% | -7.6% | ||
| OMEG | OMEGA ALPHA SPACcl a | $993,000 | +0.8% | 100,000 | 0.0% | 0.36% | -7.6% | |
| ARYD | ARYA SCIENCES ACQU CORP IVcl a | $991,000 | +1.0% | 100,000 | 0.0% | 0.36% | -7.6% | |
| New | AMYLYX PHARMACEUTICALS INC | $985,000 | – | 35,000 | +100.0% | 0.36% | – | |
| RENOVACOR INC | $980,000 | +24.4% | 388,845 | 0.0% | 0.36% | +14.0% | ||
| AVTE | New | AEROVATE THERAPEUTICS INC | $846,000 | – | 51,000 | +100.0% | 0.31% | – |
| COLISEUM ACQUISITION CORP | $835,000 | +1.0% | 85,000 | 0.0% | 0.31% | -7.6% | ||
| New | CLENE INCput | $788,000 | – | 281,500 | +100.0% | 0.29% | – | |
| GOEDWS | POLISHED COM INC*w exp 06/02/202 | $763,000 | -52.0% | 6,103,824 | 0.0% | 0.28% | -55.9% | |
| New | RELMADA THERAPEUTICS INCput | $674,000 | – | 18,200 | +100.0% | 0.25% | – | |
| GRIL | Sell | MUSCLE MAKER INC | $666,000 | -3.8% | 1,771,331 | -1.4% | 0.24% | -11.9% |
| DOUBLEDOWN INTERACTIVE CO LTads | $562,000 | -4.4% | 60,876 | 0.0% | 0.21% | -12.3% | ||
| PALI | New | PALISADE BIO INC | $559,000 | – | 5,643,007 | +100.0% | 0.20% | – |
| GSR II METEORA ACQUISITN CORunit 02/24/2027 | $514,000 | +3.0% | 50,000 | 0.0% | 0.19% | -6.0% | ||
| CLBR | COLOMBIER ACQUISITION CORPcl a | $488,000 | 0.0% | 50,000 | 0.0% | 0.18% | -8.2% | |
| Sell | PEPGEN INC | $363,000 | -54.3% | 40,000 | -50.0% | 0.13% | -58.2% | |
| TTOO | New | T2 BIOSYSTEMS INC | $321,000 | – | 2,840,000 | +100.0% | 0.12% | – |
| RLMD | Sell | RELMADA THERAPEUTICS INC | $315,000 | -40.8% | 8,500 | -69.6% | 0.12% | -46.0% |
| New | WEARABLE DEVICES LTD*w exp 09/14/202 | $295,000 | – | 1,411,600 | +100.0% | 0.11% | – | |
| New | AMYLYX PHARMACEUTICALS INCput | $253,000 | – | 9,000 | +100.0% | 0.09% | – | |
| BNTC | New | BENITEC BIOPHARMA INC | $245,000 | – | 658,796 | +100.0% | 0.09% | – |
| New | TWIN VEE POWERCATS CO | $165,000 | – | 67,798 | +100.0% | 0.06% | – | |
| New | VIGIL NEUROSCIENCE INC | $144,000 | – | 15,788 | +100.0% | 0.05% | – | |
| ZEVWS | LIGHTNING EMOTORS INC*w exp 05/18/202 | $120,000 | -52.9% | 652,173 | 0.0% | 0.04% | -56.9% | |
| NBY | New | NOVABAY PHARMACEUTICALS INC | $121,000 | – | 1,095,957 | +100.0% | 0.04% | – |
| TC BIOPHARM HOLDINGS PLC*w exp 02/08/202 | $118,000 | -47.1% | 941,176 | 0.0% | 0.04% | -51.7% | ||
| HARBOR CUSTOM DEVELOPMENT IN*w exp 10/04/202 | $114,000 | -53.3% | 650,000 | 0.0% | 0.04% | -57.1% | ||
| HSAQ | HEALTH SCIENCES ACQ CORP 2 | $99,000 | -1.0% | 10,000 | 0.0% | 0.04% | -10.0% | |
| HCDIW | HARBOR CUSTOM DEVELOPMENT IN*w exp 05/09/202 | $91,000 | -21.6% | 600,000 | 0.0% | 0.03% | -28.3% | |
| NEXGEL INC*w exp 12/01/202 | $68,000 | +7.9% | 225,000 | 0.0% | 0.02% | 0.0% | ||
| New | INNOVATIVE EYEWEAR INC*w exp 08/16/202 | $60,000 | – | 150,000 | +100.0% | 0.02% | – | |
| CINGULATE INC*w exp 12/10/202 | $59,000 | -30.6% | 270,000 | 0.0% | 0.02% | -35.3% | ||
| RENOVACOR INC*w exp 99/99/999 | $58,000 | +13.7% | 731,561 | 0.0% | 0.02% | +5.0% | ||
| New | BRUUSH ORAL CARE INC*w exp 08/03/202 | $52,000 | – | 120,193 | +100.0% | 0.02% | – | |
| DIRECT DIGITAL HOLDINGS INC*w exp 02/15/202 | $49,000 | -30.0% | 180,000 | 0.0% | 0.02% | -35.7% | ||
| NLSPW | NLS PHARMACEUTICS LTD*w exp 09/25/202 | $43,000 | +79.2% | 200,000 | 0.0% | 0.02% | +60.0% | |
| New | JEFFS BRANDS LTD*w exp 08/26/202 | $40,000 | – | 240,385 | +100.0% | 0.02% | – | |
| CEA INDUSTRIES INC*w exp 02/11/202 | $38,000 | -36.7% | 250,000 | 0.0% | 0.01% | -41.7% | ||
| LAKESHORE ACQUISITION I CORP*w exp 07/15/202 | $30,000 | +11.1% | 150,000 | 0.0% | 0.01% | 0.0% | ||
| New | ONFOLIO HOLDINGS INC*w exp 01/02/202 | $30,000 | – | 200,000 | +100.0% | 0.01% | – | |
| PEPPERLIME HEALTH ACQUSTN CO*w exp 10/01/202 | $27,000 | -64.5% | 367,500 | 0.0% | 0.01% | -66.7% | ||
| MBTCR | NOCTURNE ACQUISITION CORPright 12/26/2025 | $22,000 | +10.0% | 500,000 | 0.0% | 0.01% | 0.0% | |
| New | NEXALIN TECHNOLOGY INC*w exp 09/15/202 | $19,000 | – | 105,000 | +100.0% | 0.01% | – | |
| SURROZEN INC*w exp 08/01/203 | $15,000 | -6.2% | 82,233 | 0.0% | 0.01% | -16.7% | ||
| CHAVANT CAPITAL ACQUISITN CO*w exp 99/99/999 | $7,000 | -36.4% | 150,000 | 0.0% | 0.00% | -25.0% | ||
| OPY ACQUISITION CORP I*w exp 09/22/202 | $5,000 | -44.4% | 50,000 | 0.0% | 0.00% | -50.0% | ||
| EUCRW | EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202 | $5,000 | -44.4% | 133,333 | 0.0% | 0.00% | -50.0% | |
| AULT DISRUPTIVE TECHS CORP*w exp 99/99/999 | $5,000 | -28.6% | 112,500 | 0.0% | 0.00% | -33.3% | ||
| SRSAW | SARISSA CAPITAL ACQUISITN CO*w exp 10/23/202 | $2,000 | -66.7% | 75,000 | 0.0% | 0.00% | -50.0% | |
| GIGINTERNATIONAL1 INC*w exp 04/19/202 | $3,000 | -25.0% | 50,000 | 0.0% | 0.00% | -50.0% | ||
| CLBRWS | COLOMBIER ACQUISITION CORP*w exp 99/99/999 | $2,000 | 0.0% | 16,666 | 0.0% | 0.00% | 0.0% | |
| COLISEUM ACQUISITION CORP*w exp 08/22/202 | $2,000 | -33.3% | 28,333 | 0.0% | 0.00% | 0.0% | ||
| INDUSTRIAL HUMAN CAPITAL INC*w exp 11/27/202 | $2,000 | -50.0% | 100,000 | 0.0% | 0.00% | -50.0% | ||
| TMPMW | TURMERIC ACQUISITION CORP*w exp 10/08/202 | $2,000 | -75.0% | 84,666 | 0.0% | 0.00% | -66.7% | |
| Exit | SONENDO INC | $0 | – | -37,572 | -100.0% | -0.03% | – | |
| BBIO | Exit | BRIDGEBIO PHARMA INCcall | $0 | – | -17,400 | -100.0% | -0.06% | – |
| DBGI | Exit | DIGITAL BRANDS GROUP INC | $0 | – | -1,000,000 | -100.0% | -0.08% | – |
| IMTXW | Exit | IMMATICS N.V*w exp 07/01/202 | $0 | – | -97,467 | -100.0% | -0.08% | – |
| Exit | SURGEPAYS INC*w exp 10/22/202 | $0 | – | -250,000 | -100.0% | -0.12% | – | |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -15,000 | -100.0% | -0.19% | – |
| GERN | Exit | GERON CORP | $0 | – | -371,367 | -100.0% | -0.23% | – |
| ATHA | Exit | ATHIRA PHARMA INCcall | $0 | – | -200,100 | -100.0% | -0.24% | – |
| STOK | Exit | STOKE THERAPEUTICS INC | $0 | – | -48,000 | -100.0% | -0.25% | – |
| Exit | LIANBIOsponsored ads | $0 | – | -315,191 | -100.0% | -0.27% | – | |
| Exit | HOLLEY INC | $0 | – | -80,000 | -100.0% | -0.34% | – | |
| RXDX | Exit | PROMETHEUS BIOSCIENCES INC | $0 | – | -39,000 | -100.0% | -0.44% | – |
| ALT | Exit | ALTIMMUNE INC | $0 | – | -98,659 | -100.0% | -0.46% | – |
| IMGN | Exit | IMMUNOGEN INC | $0 | – | -280,000 | -100.0% | -0.50% | – |
| TWND | Exit | TAILWIND ACQUISITION CORP | $0 | – | -128,414 | -100.0% | -0.51% | – |
| MORF | Exit | MORPHIC HLDG INC | $0 | – | -60,000 | -100.0% | -0.52% | – |
| RZLT | Exit | REZOLUTE INC | $0 | – | -411,000 | -100.0% | -0.53% | – |
| OM | Exit | OUTSET MED INC | $0 | – | -103,880 | -100.0% | -0.62% | – |
| AGIO | Exit | AGIOS PHARMACEUTICALS INC | $0 | – | -73,000 | -100.0% | -0.65% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INCput | $0 | – | -50,000 | -100.0% | -0.77% | – |
| Exit | CHAVANT CAPITAL ACQUISITN COordinary shares | $0 | – | -200,000 | -100.0% | -0.80% | – | |
| Exit | LAKESHORE ACQUISITION I CORPordinary shares | $0 | – | -200,000 | -100.0% | -0.80% | – | |
| Exit | GIGINTERNATIONAL1 INC | $0 | – | -200,000 | -100.0% | -0.80% | – | |
| SWAV | Exit | SHOCKWAVE MED INC | $0 | – | -12,000 | -100.0% | -0.92% | – |
| HRMY | Exit | HARMONY BIOSCIENCES HLDGS IN | $0 | – | -50,000 | -100.0% | -0.98% | – |
| MASS | Exit | 908 DEVICES INC | $0 | – | -125,000 | -100.0% | -1.03% | – |
| KURA | Exit | KURA ONCOLOGY INC | $0 | – | -147,000 | -100.0% | -1.08% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -85,000 | -100.0% | -1.09% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INCcall | $0 | – | -365,100 | -100.0% | -1.16% | – |
| LIVN | Exit | LIVANOVA PLC | $0 | – | -50,000 | -100.0% | -1.25% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -44,000 | -100.0% | -1.31% | – |
| Exit | AMYLYX PHARMACEUTICALS INCput | $0 | – | -200,000 | -100.0% | -1.54% | – | |
| GH | Exit | GUARDANT HEALTH INCcall | $0 | – | -100,000 | -100.0% | -1.61% | – |
| STAA | Exit | STAAR SURGICAL CO | $0 | – | -75,000 | -100.0% | -2.13% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FAT BRANDS INC | 12 | Q3 2023 | 0.6% |
| CHINOOK THERAPEUTICS INC | 11 | Q2 2023 | 8.9% |
| BELLUS HEALTH INC NEW | 10 | Q1 2023 | 4.7% |
| XTANT MED HLDGS INC | 10 | Q3 2023 | 5.1% |
| IVERIC BIO INC | 10 | Q1 2023 | 2.3% |
| MYRIAD GENETICS INC | 10 | Q1 2023 | 2.3% |
| HARBOR CUSTOM DEVELOPMENT IN | 10 | Q3 2023 | 0.1% |
| CRINETICS PHARMACEUTICALS IN | 9 | Q3 2023 | 4.1% |
| CTI BIOPHARMA CORP | 9 | Q1 2023 | 2.6% |
| POLISHED COM INC | 9 | Q2 2023 | 3.4% |
View Altium Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Marpai, Inc. | April 26, 2023 | 1,805,327 | 6.2% |
| Astria Therapeutics, Inc. | February 14, 2023 | 1,355,372 | 5.0% |
| HyreCar Inc. | February 14, 2023 | 1,688,120 | 5.6% |
| Muscle Maker, Inc. | February 14, 2023 | 2,888,085 | 5.0% |
| NeuroBo Pharmaceuticals, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| PALISADE BIO, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| 1847 Goedeker Inc. | February 14, 2022 | 6,103,824 | 5.0% |
| BioRestorative Therapies, Inc. | February 14, 2022 | 200,000 | 5.0% |
| BriaCell Therapeutics Corp. | February 14, 2022 | 900,000 | 4.7% |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | February 14, 2022 | 363,000 | 5.0% |
View Altium Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-02-21 |
| SC 13G | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View Altium Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.